Related Experiment Video
Updated: Jun 10, 2026

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Formulation of a stable and high-loaded quercetin injectable emulsion
Huizhu Sun1, Heming Xu, Xinggang Yang
1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, P R China.
Abstract:
The purpose of this paper was to prepare a stable and high-loaded quercetin emulsion with the quercetin-phospholipid complex. The complex was analyzed by FT-IR and SEM. Quercetin and soybean lecithin were reacted in dichloromethane at a ratio of 1:2.5 for 2 h at 40°C to prepare the complex. The optimum quercetin emulsion formulation consisted of (according to quality percentage), the complex (quercetin 0.06% in the emulsion), miglyol 812 10%, soybean oil 2%, solutol HS 15 1.2%, cremophor ELP 0.4%, vitamin E 0.2%, oleic acid 0.5%, glycerol 2.5%. The quercetin emulsion was sterilized at 121°C for 15 min. The drug content and particle size distribution of the emulsion before and after sterilization were almost unchanged. The results of accelerate stability (stored at 40°C over one month) and short-time stability (stored at room temperature over six months) tests showed that the quercetin emulsion had enough physicochemical stability to undergo storage. The histopathological examination for rabbit ear vein irritation test indicated that the quercetin emulsion produced no more irritation than normal saline.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioavailability Enhancement: Drug Permeability Enhancement
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
